Development of tuberculosis infection control guidelines in a pediatric HIV clinic in sub-Saharan Africa

J G Carlucci1, L Jin2, J E Sanders1

  • 1Baylor College of Medicine Children's Foundation, Lesotho, Maseru, Lesotho ; Baylor International Pediatric AIDS Initiative at Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

Public Health Action
|September 25, 2015
PubMed

Insights

Developing infection control (IC) guidelines for human immunodeficiency virus (HIV) and tuberculosis (TB) in resource-limited settings is feasible. Prioritizing education and administrative support ensures effective implementation and sustainability.

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Healthcare Management

Background:

  • Established pediatric HIV clinic in Lesotho faced challenges with expanding services to include tuberculosis (TB) management.
  • Existing infection control (IC) measures primarily focused on blood-borne diseases, necessitating updated protocols for airborne pathogens like TB.
  • International recommendations guided the expansion of services and the need for comprehensive IC guidelines.

Purpose of the Study:

  • To develop a feasible model for creating and implementing IC guidelines in ambulatory care settings within resource-limited areas.
  • To address the high prevalence of both HIV and TB in the target region.
  • To integrate general and TB-specific IC measures, emphasizing administrative and environmental controls.

Main Methods:

  • An interdisciplinary committee was formed to guide the development, implementation, and monitoring of IC guidelines.
  • Guidelines were created by synthesizing local needs with international best practices for IC.
  • Emphasis was placed on administrative measures, environmental controls, and disease-specific precautions for TB and HIV.

Main Results:

  • The development and implementation of comprehensive IC guidelines in a resource-limited setting were found to be achievable.
  • Key components included integrating general and TB-specific measures, with a strong focus on administrative support.
  • Education emerged as a critical element for the successful adoption of IC practices.

Conclusions:

  • Implementing robust IC guidelines in resource-limited settings with high HIV and TB burdens is practical and essential.
  • Sustainability of IC programs relies heavily on administrative backing and institutional commitment.
  • Many effective IC interventions require minimal resources and expertise, making them accessible for widespread adoption.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
870
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
707
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377